Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie

Perspektiven der Wirtschaftspolitik

Volumn 7, Issue , 2006, Pages 49-73

  Felder, Stefan ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; MEDICAL GEOGRAPHY; MODELING; THEORETICAL STUDY;

CENTRAL EUROPE; EURASIA; EUROPE; GERMANY;

EID: 44649132887     PISSN: 14656493     EISSN: 14682516     Source Type: Journal    
DOI: 10.1111/j.1465-6493.2006.00216.x     Document Type: Article

References (42)

1. Ashenfelter, O. (2004), Using Mandatory Speed Limits to Measure the Value of a Statistical Life, Journal of Political Economy 112, S227-S267, Part 2.
2. Arthur, W. B. (1981), The Economics of Risks to Life, American Economic Review 71, 54-64.
3. AWMF online (1999), Deutsche Gesellschaft fur Gynakologie und Geburtshilfe, Deutsche Gesellschaft fur Kinderheilkunde und Jugendmedizin, Deutsche Gesellschaft fur Perinatale Medizin und Gesellschaft fur Neonatologie und Padiatrische Intensivmedizin, Frühgeburt an der Grenze der Lebensfahigkeit des Kindes, Leitlinie Nr. 024/019 von 1999, www.awmf.de.
4. Bakhai, A. (2003), Cost-Effectiveness of Coronary Stenting and Abciximab for Patients with Acute Myocardial Infarction. Results form the CADILLAC Trial, Circulation 108, 2857-2863.
5. Baker, J. P. (1996), The Machine in the Nursery: Incubator Technology and the Origins of Newborn Intensive Care. The Johns Hopkins University Press, Baltimore, MD.
6. Baumol, W. J. (1967), Macroeconomics of Unbalanced Growth: The Anatomy of Urban Crisis, American Economic Review 57, 415-426.
7. Berger, T. M., V. B. Üttiker, J.-C. Fauchere, W. Holzgreve, C. H. Kind, R. Largo, A. Moessinger und R. Zimmermann (2002), Empfehlungen zur Betreuung von Frühgeborenen an der Grenze der Lebensfahigkeit (Gestationsalter 22-26 SSW), Schweizerische Arztezeitung 83, 171-176 oder www.neonet.ch.
8. Breyer, F. (2005), Life Expectancy and Health Care Expenditures in the 21st Century: A New Calculation for Germany Using the Costs of Dying, Health Policy (forthcoming).
9. Breyer, F. (2000), Gesundheitsausgaben, Alter und medizinischer Fortschritt: Eine Regressionsanalyse, Jahrbücher für Nationalökonomie und Statistik 220, 1-17.
10. Busse, R. C. Krauth und F.W. Schwartz (2002), Use of Acute Hospital Beds Does not Increase as the Population Ages: Results for a Seven Year Cohort Study in Germany, Journal of Epidemiology and Community Health 56, 289-293.
11. Clemente, J. C. Marcuello, A. Montanes und F. Pueyo (2004), On the International Stability of Health Care Expenditure Functions: Are Government and Private Functions Similar?, Journal of Health Economics 23, 589-613.
12. Costa D. L. (2004), Changes in the Value of Life, 1940-1980, Journal of Risk and Uncertainty 29, 159-180.
13. Cutler, D. M. (2001), Is Technological Change in Medicine Worth It?, Health Affairs 20, 11-29.
14. Cutler, D. M. (2000), The Technology of Birth: Is it Worth It?, in: A. Garber (Hrsg.), Frontiers in Health Policy Research. Vol. 3. Cambridge University Press, 33-67.
15. Felder S. (2006), The Longevity Gender Gap: Explaining the Difference between Singles and Couples, Journal of Population Economics (forthcoming).
16. Felder S. (2002), Glykoprotein-IIb/IIIa-Rezeptor-Antagonisten in der Therapie von akuten Koronarsyndromen, Internistische Praxis 42, 837-848.
17. Felder S., M. Schmitt (2000), Health Care Expenditure in the Last Months of Life, Journal of Health Economics 19, 679-695.
18. Friedman, M. (1992), Input and Output in Medical Care, Stanford, California, Hoover Institution, Stanford University.
19. Getzen, T. (2000), Health Care is an Individual Necessity and a National Luxury: Applying Multilevel Decision Models to the Analysis of Health Care Expenditure, Journal of Health Economics 19, 259-270.
20. Hall, R. E. (2005), The Value and the Rise in Health Spending, mimeo, Department of Economics, U. C. Berkeley, August 24, 2005 - Version 3.0, http://www.elsa.berkeley.edu/∼chad/.
21. Kramer, W. (1996), Hippokrates und Sisyphus. Die moderne Medizin als Opfer ihres eigenen Erfolgs, in: W. Kirch und H. Kliemt (Hrsg.), Rationierung im Gesundheitswesen. Regensburg.
22. Kuhn, T. (1970), The Structure of Scientific Revolutions. 2nd ed. University of Chicago Press, Chicago.
23. Leung M.C.M. J. Zhang und J. Zhang (2004), An Economic Analysis of Life Expectancy by Gender with Application to the United States, Journal of Health Economics 23, 737-759.
24. Lubitz J. B.(1993), Trends in Medicare Payments in the Last Year of Life, New England Journal of Medicine 328, 1092-1096.
25. Lubitz J.D. J. Beebe, und C. Baker (1995), Longevity and Medicare Expenditures, The New England Journal of Medicine 332, 999-1003.
26. Meads C. (2000), Coronary Artery Stents in the Treatment of Ischaemic Heart Disease: A Rapid and Systematic Review, Health Technology Assessment 4, No. 23.
27. Meltzer, D. (1997), Accounting for Future Costs in Medical Cost-Effectiveness Analysis, Journal of Health Economics 16, 33-64.
28. Murphy, K. M. (2005), The Value of Health and Longevity, NBER Working Paper Series No. 11405.
29. Newhouse, J. P. (1992), Medical Care Costs: How Much Welfare Loss? Journal of Economic Perspectives 6, 3-21.
30. OECD (2005), OECD Health Data, OECD, Paris.
31. österreichische Gesellschaft fur Kinder- und Jugendheilkunde (2005), Erstversorgung von Frühgeborenen an der Grenze der Lebensfahigkeit, www.docs4you.at.
32. Rosen, S. (1988), The Value of Changes in Life Expectancy, Journal of Risk and Uncertainty 1, 285-304.
33. Schmoller, G. (1883), Eröffnungsrede, in: Verhandlungen der Eisenacher Versammlung zur Besprechung der socialen Frage am 6. und 7. Oktober 1872 - stenographische Niederschrift von Heinrich Roller. Duncker und Humblot, Leipzig.
34. Schulz, E. R. Leidl und H.H. Konig (2004), The Impact of Ageing on Hospital Care and Long-term Care - the Example of Germany, Health Policy 67, 57-74.
35. Seshamani M. (2004), Ageing and Health Care Expenditure: The Red Herring Argument Revisited, Health Economics 13, 303-314.
36. Spillman, B. C. (2000), The Effect of Longevity on Spending for Acute and Long-Term Care, New England Journal of Medicine 342, 1409-1415.
37. Stearns S. C. (2004), Time to Include Time to Death? The Future of Health Care Expenditure Predictions, Health Economics 13, 315-327.
38. Viscusi, W. K. (2003), The Value of a Statistical Life: A Critical Review of Market Estimates throughout the World, Journal of Risk and Uncertainty 27, 5-76.
39. Werblow, A. S. Felder und P. Zweifel (2005), Population Ageing and Health Care Expenditure: A School of ‘Red Herrings’?, FEMM Discussion Paper 11/05, July 2005.
40. Wood N. S. N. Marlow, K. Costeloe, A. T. Gibson und A. R. Wilkenson (2000), Neurologic and Developmental Disability after Extremely Preterm Birth, EPICure Study Group, New England Journal of Medicine 343, 378-384.
41. Zweifel, P. S. Felder und A. Werblow (2004), Population Ageing and Health Care Expenditure: New Evidence on the ‘Red Herring’;, Geneva Papers on Risk and Insurance: Issues and Practice, Special Issue on Health Insurance 29, 653-667.
42. Zweifel, P. S. Felder und M. Meier (1999), Ageing of Population and Health Care Expenditure: A Red Herring?, Health Economics 8, 485-496.